|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/113 | |
| A61K 31/713 | |||
| A61P 11/00 | |||
| A61P 27/00 |
| (11) | Number of the document | 2319925 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11153604.1 |
| Date of filing the European patent application | 2005-08-16 | |
| (97) | Date of publication of the European application | 2011-05-11 |
| (45) | Date of publication and mention of the grant of the patent | 2018-07-25 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 601983 P | 2004-08-17 | US | |
| 604668 P | 2004-08-25 | US | |
| 609786 P | 2004-09-14 | US | |
| 638659 P | 2004-12-22 | US | |
| 664236 P | 2005-03-22 | US | |
| 688943 P | 2005-06-08 | US | |
| 04019405 | 2004-08-16 | EP |
| (72) |
Feinstein, Elena, IL
Kaufmann, Jörg, DE
Giese, Klaus, DE
|
| (73) |
Quark Pharmaceuticals, Inc.,
6501 Dumbarton Circle, Fremont, California 94555,
US
Silence Therapeutics GmbH, Robert-Rössle-Strasse 10, 13125 Berlin, DE |
| (54) | Therapeutic uses of inhibitors of RTP801 |
| Therapeutic uses of inhibitors of RTP801 |